We all must thankful to the researchers that they are busy in finding new ways to treat different diseases and try to find the easy and less painful ways to treat different diseases. Now the researchers of the University of the Southern California found a new way to treat the dangerous disease HIV.
According to the Keck School of Medicine of USC researcher that the medical conduct that targets human proteins rather than ever-mutating viruses may one day help HIV-positive people whose bodies have built confrontation to “cocktails” make them healthy.
13 years of research is done by I-Chueh about how the human immune system panels infections. And now his lab shows that a protein modified that can be targeted to save the human immunodeficiency virus from damaging HIV-positive individuals.
The assistant professor of the molecular microbiology and immunology at the Keck School of Medicine, which ranked No. 1 in National Institutes of Health funds got per principal investigator in 2016. The professor said that “Most HIV drugs target the virus. But the virus is not stable; it always mutates problematic because the virus can become resistant to effective drugs.”
The study which was published in the July 3 issue of the “Proceedings of the National Academy of Sciences” is the initial step towards allowing the doctor to direct the body’s own immune system to improved dispute off disease. This procedure is different from the traditional method of targeting virus.
Huang said, “Much more research needs to be done, but we may have identified a new approach to treating acute HIV infection.”
The latest study is working on the HIV-1 which is the most widespread around the world. The Huang’s lab found family proteins that stop highly contagious virus including SARS, dengue virus, the flu, and West Nile virus from viral replication at the initial point of infection.
Huang lab found a novel variant with in the formerly recognized family proteins and they keep its nickname Delta 20 and this protein helps to control the most dangerous HIV stain X4, by saving the virus from infecting the cells.
Huang said “Our finding will not help develop a vaccine because the focus is on innate immunity rather than the virus. Perhaps one day scientists will create medicine that, like “HIV cocktails” have to be taken indefinitely. But the new treatment may be more effective because it is harder for viruses to escape the body defenses.”